{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:45:14Z","timestamp":1787312714039,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000295","name":"Epilepsy Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejpn.2019.12.010","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T02:29:15Z","timestamp":1576808955000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Neurodevelopmental outcomes in paediatric immune-mediated and autoimmune epileptic encephalopathy"],"prefix":"10.1016","volume":"24","author":[{"given":"Sukhvir K.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-6858","authenticated-orcid":false,"given":"Amanda G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2019.12.010_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/dmcn.13169","article-title":"N-methyl-d-aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression","volume":"58","author":"Hacohen","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/archdischild-2014-306795","article-title":"N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children","volume":"100","author":"Wright","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejpn.2019.12.010_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ejpn.2019.12.010_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","article-title":"Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study","volume":"4","author":"Peer","year":"2017","journal-title":"The Lancet. Psychiatr."},{"key":"10.1016\/j.ejpn.2019.12.010_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib11","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1523\/JNEUROSCI.2761-07.2007","article-title":"Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy","volume":"27","author":"Huberfeld","year":"2007","journal-title":"J.\u00a0Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejpn.2019.12.010_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.114.212779","article-title":"Perampanel, an antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models","volume":"351","author":"Zwart","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpn.2019.12.010_bib13","first-page":"765","article-title":"Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis","volume":"263","author":"Matricardi","year":"2016","journal-title":"J.\u00a0Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2019.12.010_bib14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/arclin\/acy088","article-title":"Neuropsychological and psychopathological profile of anti-nmdar encephalitis: a possible pathophysiological model for pediatric neuropsychiatric disorders","volume":"34","author":"Cainelli","year":"2019","journal-title":"Arch. Clin. Neuropsychol. :Off. J. Natl. Acad. Neuropsychologists"},{"key":"10.1016\/j.ejpn.2019.12.010_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13854046.2016.1191676","article-title":"Neuropsychological characterization of three adolescent females with anti-NMDA receptor encephalitis in the acute, post-acute, and chronic phases: an inter-institutional case series","volume":"31","author":"Hinkle","year":"2017","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib16","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/brain\/awr103","article-title":"Do children really recover better? Neurobehavioural plasticity after early brain insult","volume":"134","author":"Anderson","year":"2011","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2019.12.010_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejpn.2017.11.005","article-title":"Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies","volume":"22","author":"Caputo","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2019.12.010_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejpn.2018.01.002","article-title":"Severe GABAA receptor encephalitis without seizures: a paediatric case successfully treated with early immunomodulation","volume":"22","author":"Nikolaus","year":"2018","journal-title":"Eur. J. Paediatr. Neurol: EJPN. Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"10.1016\/j.ejpn.2019.12.010_bib22","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1212\/NXI.0000000000000552","article-title":"GABAA receptor autoimmunity: a multicenter experience","volume":"6","author":"O'Connor","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.ejpn.2019.12.010_bib23","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejpn.2017.08.004","article-title":"Limbic encephalitis with LGI1 antibodies in a 14-year-old boy","volume":"22","author":"Schimmel","year":"2018","journal-title":"Eur. J. Paediatr. Neurol: EJPN. Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"10.1016\/j.ejpn.2019.12.010_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2019.12.010_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaneurol.2013.4786","article-title":"Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity","volume":"71","author":"Kruer","year":"2014","journal-title":"JAMA neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib27","first-page":"450","article-title":"Patient characteristics and outcome associations in AMPA receptor encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpn.2015.12.011","article-title":"Antibodies to AMPA receptors in Rasmussen's encephalitis","volume":"20","author":"Nibber","year":"2016","journal-title":"Eur. J. Paediatr. Neurol. : EJPN. Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"10.1016\/j.ejpn.2019.12.010_bib29","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib30","first-page":"1290","article-title":"Antiglycine receptor antibody related disease: a case series and literature review","volume":"25","author":"Swayne","year":"2018"},{"key":"10.1016\/j.ejpn.2019.12.010_bib31","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Arino","year":"2015","journal-title":"JAMA neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.2010.183897","article-title":"Limbic encephalitis in children and adolescents","volume":"96","author":"Haberlandt","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejpn.2019.12.010_bib33","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11940-012-0170-0","article-title":"Treatment of acute disseminated encephalomyelitis","volume":"14","author":"Pohl","year":"2012","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/spid.2003.127225","article-title":"Acute disseminated encephalomyelitis","volume":"14","author":"Dale","year":"2003","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.ejpn.2019.12.010_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11065-017-9343-7","article-title":"Long-term neuropsychological outcomes of childhood onset acute disseminated encephalomyelitis (ADEM): a meta-analysis","volume":"27","author":"Burton","year":"2017","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.ejpn.2019.12.010_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pediatrneurol.2004.03.008","article-title":"Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset","volume":"31","author":"Jacobs","year":"2004","journal-title":"Pediatr. Neurol."},{"issue":"14","key":"10.1016\/j.ejpn.2019.12.010_bib38","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2019.12.010_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2019.12.010_bib40","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.ejpn.2019.12.010_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA neurology"},{"key":"10.1016\/j.ejpn.2019.12.010_bib42","article-title":"Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis","author":"Rossor","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2019.12.010_bib43","first-page":"958","article-title":"Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes","volume":"60","author":"Duignan","year":"2018"},{"key":"10.1016\/j.ejpn.2019.12.010_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.msard.2018.12.001","article-title":"Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination","volume":"28","author":"Zhou","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ejpn.2019.12.010_bib45","first-page":"127","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018"},{"key":"10.1016\/j.ejpn.2019.12.010_bib46","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A\u00a0score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ejpn.2019.12.010_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220042","article-title":"Understanding parental perspectives on outcomes following paediatric encephalitis: A qualitative study","volume":"14","author":"Lemon","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2019.12.010_bib48","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib49","first-page":"3218","article-title":"Positive allosteric modulation as a potential therapeutic strategy in anti-NMDA receptor encephalitis","volume":"38","author":"Warikoo","year":"2018"},{"key":"10.1016\/j.ejpn.2019.12.010_bib50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.23932","article-title":"Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis","volume":"74","author":"Finke","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2019.12.010_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069318","article-title":"Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis","volume":"8","author":"Tewarie","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ejpn.2019.12.010_bib53","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1177\/1352458518810260","article-title":"Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS","volume":"25","author":"Schoonhoven","year":"2019","journal-title":"Mult. Scler."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819304301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819304301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:36:49Z","timestamp":1761071809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379819304301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":53,"alternative-id":["S1090379819304301"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.12.010","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodevelopmental outcomes in paediatric immune-mediated and autoimmune epileptic encephalopathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}